SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001851734-23-000069
Filing Date
2023-02-16
Accepted
2023-02-15 19:49:13
Documents
15
Period of Report
2023-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230215_8k.htm   iXBRL 8-K 30150
2 EXHIBIT 10.1 ex_476465.htm EX-10.1 12192
3 EXHIBIT 10.2 ex_476466.htm EX-10.2 12390
  Complete submission text file 0001851734-23-000069.txt   185688

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arch-20230214.xsd EX-101.SCH 3602
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230214_def.xml EX-101.DEF 10837
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230214_lab.xml EX-101.LAB 14481
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230214_pre.xml EX-101.PRE 10883
9 EXTRACTED XBRL INSTANCE DOCUMENT arch20230215_8k_htm.xml XML 2411
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 23636848
SIC: 3841 Surgical & Medical Instruments & Apparatus